Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Albany Molecular Research Inc (NASDAQ:AMRI)

16.81
Delayed Data
As of 11:13am ET
 +0.14 / +0.84%
Today’s Change
12.45
Today|||52-Week Range
20.59
-15.31%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Revenue and IncomeNet Revenues126.4M105.6M120.8M152.7M
 
 
 
 
 
Cost of Goods Sold84.1M70.8M74.5M108.5M
 
 
 
 
 
Depreciation And Amortization8.4M8.5M7.8M15.0M
 
 
 
 
 
 
Operating ExpensesGross Income33.9M26.2M38.6M29.3M
 
 
 
 
 
General Expenses24.9M27.8M31.4M41.9M
 
 
 
 
 
Research And Development2.7M3.2M3.5M4.6M
 
 
 
 
 
Total Operating Expenses117.4M107.1M113.6M165.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income9.0M-1.6M7.2M-12.7M
 
 
 
 
 
Extraordinary Charge-2.8M-2.6M-7.1M-3.0M
 
 
 
 
 
Interest Expense On Debt6.8M7.1M7.1M12.7M
 
 
 
 
 
Other Expenses319.0K-997.0K740.0K-549.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-245.0K-12.3M-6.3M-28.9M
 
 
 
 
 
Income Taxes-2.0M-2.2M-15.0M-5.5M
 
 
 
 
 
Net Income1.8M-10.1M-21.3M-23.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS35.6M34.7M34.9M41.3M
 
 
 
 
 
Shares To Calculate EPS Diluted35.6M34.7M34.9M41.3M
 
 
 
 
 
 
Earnings Per ShareEPS$0.05-$0.29-$0.61-$0.57
 
 
 
 
 
EPS Diluted$0.05-$0.29-$0.61-$0.57